Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo.
Ford SJ, Obeidy P, Lovejoy DB, Bedford M, Nichols L, Chadwick C, Tucker O, Lui GY, Kalinowski DS, Jansson PJ, Iqbal TH, Alderson D, Richardson DR, Tselepis C.
Ford SJ, et al. Among authors: chadwick c.
Br J Pharmacol. 2013 Mar;168(6):1316-28. doi: 10.1111/bph.12045.
Br J Pharmacol. 2013.
PMID: 23126308
Free PMC article.